Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios

Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, will present an in-depth exploration of medical device regulations, for pharmacovigilance professionals seeking mastery in compliance and operational excellence.

UK Biobank and DNAnexus Collaboration Earns Bio-IT World 2024 Innovative Best Practices Global Impact Award for 500,000 Whole Genomes Data Release

DNAnexus announced that its ongoing collaboration with UK Biobank will be recognized with the 2024 Innovative Best Practices Global Impact Award at the upcoming Bio-IT World Conference and Expo.

SPT Labtech Appoints Rob Walton as New Chief Executive Officer

Dotmatics Luma Lab Connect Unlocks the Untapped Value of Lab Instrument Data to Accelerate Scientific R&D Decision-Making

Luma Lab Connect automatically centralizes, parses, and models data from lab instruments and other data sources for deeper analysis and insights on one harmonized, low-code cloud platform.

DNAnexus and Oracle Collaborate to Advance Precision Health

DNAnexus announced a collaboration with Oracle to advance precision health.

ProPharma Announces Changes to Its Executive Leadership Team

ProPharma announces changes to its executive leadership team with strategic appointments to propel global growth

Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions

Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announces its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms.

Bios Health Group Unveils Bios Innovation Circle™

Bios Health Group Unveils Bios Innovation Circle™ Groundbreaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena

ResultsCX Named ‘Major Player’ in NelsonHall’s NEAT Vendor Evaluation for CX Services Transformation

Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA

CG LIFE ACQUIRES TOOLHOUSE, SIGNIFICANTLY EXPANDING TECHNOLOGY-ENABLED OMNICHANNEL CAPABILITIES

CG Life is acquiring Toolhouse, doubling agency size and strengthening expertise in creating impactful digital experiences connecting with clinical and patient audiences.

Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration

Tome Biosciences, Inc., the programmable genomic integration (PGI) company, today announces the issuance of US Patent 11,952,571 for “Systems, Methods, and Compositions for Site-Specific Genetic Engineering Using Programmable Addition via Site-Specific Targeting Elements (PASTE)” by the US Patent and Trademark Office. This patent further protects Tome’s foundational PGI technology, integrase-mediated PGI (I-PGI), describes a system capable of performing I-PGI in a mammalian cell, and is exclusively licensed to Tome from MIT.

Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry and New Biology with Two New Preprint Papers

Model Medicines has announced the upcoming release of two groundbreaking preprint papers on bioRxiv, detailing significant advances in antiviral and oncology drug discovery using their GALILEO AI platform. The first preprint reveals the discovery of a novel broad-spectrum antiviral target and inhibitor, while the second introduces ChemPrint, a deep learning model that achieved a remarkable 45.5% hit rate in identifying novel inhibitors of challenging oncology targets. These findings build upon Model Medicines' recent successes and underscore the transformative potential of their AI platform in revolutionizing drug discovery.

Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs

Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site

Andaman7 Launches AI Supercharged Personal Health Record v5

Andaman7 Launches AI Supercharged Personal Health Record v5 New advanced AI Simplification, Summarization and Translation features empower patients and improve communication with healthcare providers and researchers.

Phenomix Sciences Launches Three-in-One Obesity Phenotyping Test, Adding Emotional Hunger and Personalized Lifestyle Guidance

New MyPhenome test delivers patients and providers with the most comprehensive and actionable insights yet into their obesity type(s).

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

AONL and Laudio Release New Report Measuring the Impact of Nurse Managers on Health System Performance

Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial

Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial

Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials

Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials